Literature DB >> 2471834

Immunogenicity of ribonucleic acid-protein fraction of Mycobacterium tuberculosis encapsulated in liposomes.

P Pancholi1, V K Vinayak, G K Khuller.   

Abstract

Immunologically potent RNA-protein extracted from Mycobacterium tuberculosis strain H37Ra, when entrapped in phosphatidylcholine multilamellar liposomes and injected into mice, induced both cellular and humoral immune responses. Significant protection against infection with M. tuberculosis H37Rv was also induced in the immunised mice, as monitored by (i) higher survival rates, (ii) decreased viable counts of M. tuberculosis H37Rv in lungs, livers and spleens, (iii) lower lung density, and (iv) lower root specific lung weight, in comparison with a control group of unimmunized mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471834     DOI: 10.1099/00222615-29-2-131

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Protective efficacy of different cell-wall fractions of Mycobacterium tuberculosis.

Authors:  I B Chugh; R Kansal; V K Vinayak; G K Khuller
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

2.  Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice.

Authors:  P Deol; G K Khuller; K Joshi
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

3.  Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice.

Authors:  M Dutt; G K Khuller
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

4.  Host response to Mycobacterial cell wall subunit during experimental tuberculosis in mice.

Authors:  I B Chugh; V K Vinayak; G K Khuller
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.